<DOC>
	<DOCNO>NCT00149071</DOCNO>
	<brief_summary>A doubleblind randomised trial active versus sham rTMS combination escitalopram patient prior treatment resistant depression acute 12 week trial subsequent 24 week study phase active versus placebo citalopram</brief_summary>
	<brief_title>Transcranial Magnetic Stimulation ( rTMS ) Accelerates Response Escitalopram Major Depression</brief_title>
	<detailed_description>In study aim investigate degree rTMS apply left dorsolateral cortex relief depressive symptom treament combine antidepressive medication . The study also able supply knowledge long possible effect rTMS treatment last . In first 12 week trial participant randomise either rTMS combine escitalopram sham rTMS combine escitalopram . rTMS give daily first 3 week . The next phase relapse prevention study responder initial phase randomise either active placebo escitalopram 24 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Major depression Hamilton score 18 Age 18 75 Pregnancy og breastfeed Mental retardation organic brain disease Alcohol substance abuse Metal implant brain , pacemaker electronic implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Transcranial magnetic stimulation ( TMS )</keyword>
	<keyword>Major depression</keyword>
	<keyword>treatment resistant major depression</keyword>
</DOC>